Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis
ABSTRACTThe immunogenicity of COVID-19 vaccines in patients with liver cirrhosis remains largely unknown. The purpose of this meta-analysis was to investigate the immunogenicity of COVID-19 vaccines in patients with cirrhosis and compare the humoral and cellular immune responses following complete C...
Saved in:
Main Authors: | Lichen Ouyang (Author), Gang Lei (Author), Yeli Gong (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity of COVID-19 vaccines in patients with cirrhosis: Expected advantage for additional dose of vaccine
by: Hinpetch Daungsupawong, et al.
Published: (2024) -
A Meta-Analysis on the Safety and Immunogenicity of Covid-19 Vaccines
by: Rasha Ashmawy, et al.
Published: (2022) -
Safety and Immunogenicity of Covid-19 Vaccines in Patients with Cancer: A Network Meta-Analysis of 11357 Patients
by: Khaled Albakri, et al.
Published: (2022) -
Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis
by: Yuxuan Du, et al.
Published: (2022) -
Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines among Patients with Immune-Mediated Dermatological Diseases: A Systematic Review and Meta-analysis
by: Sonphet Chirasuthat, et al.
Published: (2024)